Subacute Stent Thrombosis After Primary Percutaneous Coronary Intervention in a Middle-Aged Anabolic Steroid–Abusing Bodybuilder

Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction

Early ST within 30 days after primary percutaneous coronary intervention (PCI) in patients with ST-segment– elevation myocardial infarction (STEMI) is a serious complication, resulting in increased mortality. Three of 4 randomized trials have demonstrated an increased risk of acute (≤24 hours) ST with bivalirudin compared with heparin with either routine or provisional glycoprotein IIb/IIIa rec...

In stent restenosis after percutaneous coronary intervention

Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial

Several studies have reported that the antioxidant properties of melatonin can provide cardiac protection through scavenging of free radicals. This study sought to investigate the efficacy of melatonin on cardiac biomarkers, myocardial-specific protein high sensitive troponin-T (hs-TnT) and creatine kinase-MB (CK-MB), in patients with ST-segment elevation myocardial infarction (STEMI) undergoin...

Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial

Several studies have reported that the antioxidant properties of melatonin can provide cardiac protection through scavenging of free radicals. This study sought to investigate the efficacy of melatonin on cardiac biomarkers, myocardial-specific protein high sensitive troponin-T (hs-TnT) and creatine kinase-MB (CK-MB), in patients with ST-segment elevation myocardial infarction (STEMI) undergoin...

Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.

Primary percutaneous coronary intervention (PCI) is the preferred treatment for patients with ST-segment elevation myocardial infarction (STEMI) owing to improved vessel patency, decreased infarct size, lower rates of reinfarction, and improved survival compared with pharmacological reperfusion. However, stent thrombosis (ST) remains a major concern among STEMI patients with an excess 3to 4-fol...